Role of biomarkers in monitoring exposures to chemicals: present position, future prospects

References

• AITIO, A. and APOSTOLI, P. 1995, Quality assurance in biomarker measurement. Toxicology Letters, 77, 195–204.
   PubMedGoogle Scholar
• ALBERTINI, R J. 2001, Developing sustainable studies on environmental health. Mutation Research, 480–481, 317–331.
   Google Scholar
• ALBERTINI, R J., SRAM, R J., VACEK, P. M., LYNCH, J., WRIGHT, M., NICKLAS, J. A., BOOGAARD, P. J., HENDERSON, R F., SWENBERG, J. A., TATES, A. D. and WARD, J. B. 2001, Biomarkers for assessing exposures to 1,3-butadiene. Chemico-Biological Interactions, 135–136, 429–453.
   Google Scholar
• ALBERTINI, R. J., SRAM, R. J., VACEK, P. M., LYNCH, J., WRIGHT, M., NICKLAS, J. A., VAN SII I BRT, N.J., BOOGAARD, P. J., HENDERSON, R. F., SWENBERG, J. A., TATES, A. D., WARD, J. B. and WRIGHT, M. 2003, Biomarkers in Czech Workers Exposed to 1,3-Butadiene: A Transitional Epidemiologic Study. Research Report No. 116 (Cambridge, MA: Health Effects Institute).
   Google Scholar
• ALEXANDER, J., REISTAD, R., HEGSTAD, S., FRANDSEN, H., INGEBRIGTSEN, K, PAULSEN, J. E. and BECHER, G. 2002, Biomarkers of exposure to heterocyclic amines: approaches to improve the exposure assessment. Food and Chemical Toxicology, 40, 1131–1137.
   PubMed Web of Science ®Google Scholar
• BARTSC HH. 2000, Studies on biomarkers in cancer etiology and prevention: a summary and challenge of 20 years interdisciplinary research. Mutation Research, 462, 255–279.
   PubMedGoogle Scholar
• BARTSCH, H., MALAVETI I F, C., LOWENFELS, A. B., MAISONNEUVE, P., HAUTEFEUILI-E, A. and BOYLE, P. 1998b, Genetic polymorphism of N-acetyltransferases, glutathione S-transferase M1 and NAD(P)H:quinone oxidoreductase in relation to malignant and benign pancreatic disease risk. The International Pancreatic Disease Study Group. European Journal of Cancer Prevention, 7, 215–223.
   Google Scholar
• BARTSCH, H., ROJAS, M., ALEXANDROV, K. and RiscH, A. 1998a, Impact of adduct determination on the assessment of cancer susceptibility. Recent Results in Cancer Research, 154 [Special Issue: Genes and Environment in Cancer], 86–96.
   Google Scholar
• BEACH, A. C. and GurrA, R C. 1992, Human biomonitoring and the 32P-postlabelling assay. Carcinogenesis, 13, 1053–1074.
   PubMed Web of Science ®Google Scholar
• BERNARD, A. M. 1995, Biokinetic and stability aspects of biomarkers: recommendations for application in population studies. Toxicology, 101, 65–71.
   PubMedGoogle Scholar
• BOOGAARD, P. J. 2002, Use of haemoglobin adducts in exposure monitoring and risk assessment. Journal of Chromatography B, Analytical Technology Biomedical Life Sciences, 778, 309–322.
   PubMed Web of Science ®Google Scholar
• BOOGAARD, P. J. and VAN SIIIBRT, N. J. 1994, Exposure to polycyclic aromatic hydrocarbons.Occupational and Environmental Medicine, 51, 250–258.
   PubMed Web of Science ®Google Scholar
• BOOGAARD, P. J. and VAN SIIIBRT, N. J. 1995a, Biological monitoring of exposure to benzene: acomparison between S -phenyl mercapturic acid, trans, trans -muconic acid, and phenol. Occupational and Environmental Medicine, 52, 611–620.
   PubMed Web of Science ®Google Scholar
• BOOGAARD, P. J. and VAN SIII BRT, N. J. 1995b, Urinary 1-hydroxypyrene as a biomarker of exposure topolycyclic aromatic hydrocarbons in workers in petrochemical industries: baseline values and dermal uptake. Science of the Total Environment, 163, 203–209.
   Google Scholar
• BOOGAARD, P. J. and VAN SII I BRT, N. J. 1996, Suitability of S-phenyl mercapturic acid and trans, trans -muconic acid as biomarkers for exposure to low concentrations of benzene. Environmental Health Perspectives, 104 (Suppl. 6), 1151–1157.
   PubMedGoogle Scholar
• BOOGAARD, P. J., Roccin, P. S. and VAN SII I BRT, N. J. 1999, Biomonitoring of exposure to ethyleneoxide and propylene oxide by determination of hemoglobin adducts: correlations between airborne exposure and adduct levels. International Archives of Occupational and Environmental Health, 72, 142–150.
   Google Scholar
• BOOGAARD, P. J., VAN STITERT, N. J. and MEGENS, H. J. J. J. 2001, Urinary metabolites and haemoglobin adducts as biomarkers of exposure to 1,3-butadiene: A basis for 1,3-butadiene risk assessment. Chemico-Biological Interactions, 135–136, 429–453.
   Google Scholar
• BOOTH, E. D., ASTON, J. P., VAN DEN BERG, P. T. M., BAAN, R. A., RLDDICK, D. A., WADE, L. T, WRIGHT, A. S. and WATSON, W. P. 1994, Class-specific immunoadsorption purification for polycyclic aromatic hydrocarbon-DNA adducts. Carcinogenesis, 15, 2099–2106.
   Google Scholar
• BOOTH, E. D., KILGOUR, J. D., ROBINSON, S. A. and WATSON, W. P. 2004b, Dose—responses for DNA adduct formation in tissues of rats and mice exposed by inhalation to low concentrations of 1,3-[2,3-'4C]-butadiene. Chemico-Biological Interactions, 147, 195–211.
   PubMedGoogle Scholar
• BOOTH, E. D., KILGOUR, J. D. and WATSON, W. P. 2004a, Dose—responses for hemoglobin adduct formation in tissues of rats and mice exposed by inhalation to low concentrations of 1,312,3-14C] - butadiene. Chemico-Biological Interactions, 147, 213–232.
   PubMed Web of Science ®Google Scholar
• BRANDT, H. C. A. and WATSON, W. P. 2003, Monitoring human occupational and environmental exposures to polycyclic aromatic hydrocarbons. Annals of Occupational Hygiene, 47, 349–378.
   Google Scholar
• BUCKLEY, T. J. and LIOY, P. J. 1992, An examination of the time course from human dietary exposure to polycyclic aromatic hydrocarbons to urinary elimination of 1-hydroxypyrene. British Journal of Industrial Medicine, 49, 113–124.
   PubMedGoogle Scholar
• CALI-EMAN, C. J., EHRENBERG, L., JANSSON, B., OSTERMAN-GOLKAR, S., SEGERBACK, D., SVENSSON, K and WACHTMEISTER, C. A. 1978, Monitoring and risk assessment by means of alkyl groups in hemoglobin in persons occupationally exposed to ethylene oxide. Journal of Environmental Pathology and Toxicology, 2, 427–442.
   Google Scholar
• CARROQUINO, M. J., GALSON, S. K., LIGHT, J., AMLER, R W., PERERA, F. P., CLAXTON, L D. and LANDRIGAN, P. J. 1998, The US EPA conference on preventable causes of cancer in children: A research agenda. Environmental Health Perspectives, 106 (Suppl. 3), 867–873.
   PubMed Web of Science ®Google Scholar
• CHEN, Y. C. and CHEN, B.-H. 2003, Determination of polycyclic aromatic hydrocarbons in fumes from fried chicken legs. Journal of Agriculture and Food Chemistry, 51, 4162–4167.
   Google Scholar
• CLAUDIO, L, TORS, T., SANJURJO, E., SHERMAN, L R and LANDRIGAN, P. J. 1998, Environmental sciences education: a tool for achieving environmental equity and protecting children. Environ-mental Health Perspectives, 106 (Suppl. 3), 849–855.
   PubMedGoogle Scholar
• COSTA, L. G. 1996, Biomarker research in neurotoxicology: the role of mechanistic studies to bridge the gap between the laboratory and epidemiological investigations. Environmental Health Perspectives, 104, 55–67.
   PubMedGoogle Scholar
• CZENE, K., OSTERMAN-GOLKAR, S., YUN, X., Li, G., ZHAO, F., LICES PEREZ, H., Li, M., NATARAJAN, A. T. and SEGERBACK, D. 2002, Analysis of DNA and haemoglobin adducts and sister chromatid exchanges in a human population occupationally exposed to propylene oxide: a pilot study. Cancer Epidemiology and Biomarkers Prevention, 11, 315–318.
   Google Scholar
• DALLINGA, J. W., PACHEN, D. M. F. A., WIJNHOVEN, S. W. P., BREEDIJK, A., VAN'T VEER, L, WIGBOTJT, G., VAN ZANDWIJK, N., MAAS, L M., VAN AGEN, E., KLEINJANS, J. C. and VAN ScuooTEN, F J. 1998, The use of 4-aminobiphenyl hemoglobin adducts and aromatic DNA adducts in lymphocytes of smokers as biomarkers of exposure. Cancer Epidemiology and Biomarkers Prevention, 7, 571–577.
   Google Scholar
• DARCEY, D. J., EVERSON, R B., PurmAN, K L and RANDERATH, K 1992, DNA adducts and exposure to burning oil. Lancet, 339, 489.
   Google Scholar
• DE FLORA, S., IZZOTII, A., RANDERATH, K., RANDERATH, E., BARTSCH, H., NAIR, J., BALANSKY, R., VAN SCHOOTEN, F., DEGAN, P., FRONZA, G., WALSH, D. and LEvirrAs, J. 1996, DNA adducts and chronic degenerative diseases. Pathogenic relevance and implications in preventive medicine. Mutation Research, 366, 197–238.
   PubMedGoogle Scholar
• DE PALMA, G., MANINI, P., MOZZONI, P., ANDREOLL R., BERGAMASCHI, E., CAVAZZINI, S., FRANCHINI, I. and Mum, A. 2001, Polymorphism of xenobiotic-metabolizing enzymes and excretion of styrene-specific mercapturic acids. Chemical Research and Toxicology, 14, 1393–1400.
   Google Scholar
• DE Roon, B. M., COMMANDEUR, J. N. M. and VERIVIEULEN, N. P. E. 1998, Mercapturic acids as biomarkers of exposure to electrophilic chemicals: applications to environmental and industrial chemicals. Biomarkers, 3, 239–303.
   Google Scholar
• DE CAPRI°, A. P. 1999, Biomarkers of exposure and susceptibility. In General and Applied Toxicology, Vol. 3, 2nd edn, edited by B. Ballantyne, T. C. Marrs and T. Syversen (London: Macmillan), pp. 1876–1898.
   Google Scholar
• DICKEY, C., SANTELLA, R M., HATTIS, D., TANG, D., Hsu, Y, COOPER, T, YOUNG, T.-L. and PERERA, F. P. 1997, Variability in PAH—DNA adduct measurements in peripheral mononuclear cells: Implications for quantitative cancer risk assessment. Risk Analysis, 17, 649–656.
   Google Scholar
• R 1996, Nature and nurture: possibilities for cancer control. Carcinogenesis, 17, 177–184.
   PubMedGoogle Scholar
• DOR, F., and DAB, W., EMPEREUR-BISSONNET, P. and ZMIROU, D. 1999, Validity of biomarkers in environmental health studies: the case of PAHs and benzene. Critical Reviews in Toxicology, 29, 129–168.
   PubMed Web of Science ®Google Scholar
• DROZ, P. 0. 1993, Pharmacokinetic modelling as a tool for biological monitoring. Internal Archives on Occupational and Environmental Health, 65, 553–559.
   Google Scholar
• ECETOC, 2001, Genomics, Transcript Profiling, Proteomics and Metabonomics (GTPM), An Introduction. Document No. 42 (Brussels: European Centre for Ecotoxicology and Toxicology of Chemicals).
   Google Scholar
• EHRENBERG, L. 1979, Risk assessment of ethylene oxide and other compounds. In Assessing Chemical Mutagens: The Risks to Humans. Banbury Report No. 1, edited by V. K. McElheny and S. Abrahamson (New York: Cold Spring Harbor Press), pp. 157–190.
   Google Scholar
• EHRENBERG, L. 1988, Dose monitoring and cancer risk. In Methods for Detecting DNA Damage in Humans: Applications in Cancer Epidemiology and Prevention. Scientific Publ. No. 89, edited by H. Bartsch, K. Hemminki and I. K. O'Neill (Lyon: IARC), pp. 23–31.
   Google Scholar
• EHRENBERG, L., GRANATH, F. and TORNQVIST, M. 1996, Macromolecular adducts as biomarkers of exposure to environmental mutagens in human populations. Environmental Health Perspectives, 104 (Suppl. 3), 423–428.
   PubMedGoogle Scholar
• EHRENBERG, L. and OSTERMAN-GOIKAR, S. 1980, Alkylation of macromolecules for detecting mutagenic agents. Teratogenesis, Carcinogenesis and Mutagenesis, 1, 105–127.
   PubMedGoogle Scholar
• EHRENBERG, L., OSTERMAN-GOLKAR, S., SEGERBACK, D., SVENSSON, K and CALLEMAN, C. J. 1977, Evaluation of genetic risks III, Alkylation of haemoglobin after metabolic conversion of ethene to ethene oxide in vivo. Mutation Research, 45, 175–184.
   Google Scholar
• EHRENBERG., L. and TORNQVIST, M. 1992, Use of biomarkers in epidemiology: quantitative aspects. Toxicology Letters, 64–65, 485–492.
   Google Scholar
• FARMER, P. B. 1994, Carcinogen adducts: use in diagnosis and risk assessment. Clinical Chemistry, 40, 1438–1443.
   PubMedGoogle Scholar
• FARMER, P. B. 1995, Biomonitoring and molecular dosimetry of genotoxic carcinogens. In Molecular and Cellular Mechanisms of Toxicity, edited by F. De Matteis and L. L. Smith (Boca Raton: CRC Press), pp. 101–123.
   Google Scholar
• FARMER, P. B. 1999, Studies using specific biomarkers for human exposure assessment to exogenous and endogenous chemical agents. Mutation Research, 428, 69–81.
   PubMedGoogle Scholar
• GODSCHALK, R. \V., DALLINGA, J. W., WIKMAN, H., RISCH, A., KLELNJANS, J. C., BARTSCH, H. and VAN ScuourEN, F. J. 2001, Modulation of DNA and protein adducts in smokers by genetic polymorphisms in GSTM1, GSTT1, NATI and NAT2. Pharmacogenetics, 11, 389–398.
   Google Scholar
• GOLDMAN, L. R 1998, Linking research and policy to ensure children's environmental health. Environmental Health Perspectives, 106 (Suppl. 3), 857–862.
   PubMedGoogle Scholar
• GOLDONI, M., CATALANI, S., DE PALMA, G., MANINI, P., ACAMPA, 0., CORRADI, M., BERGONZI, R., AposTou, P. and Murri, A. 2004, Exhaled breath condensate as a suitable matrix to assess lung dose and effects in workers exposed to cobalt and tungsten. Environmental Health Perspectives, 112, 1293–1298.
   Google Scholar
• GRANATH, F. N., VACA, C. E., EHRENBERG, L. G. and TORNQVIST, M. A. 1999, Cancer risk estimation of genotoxic chemicals based on target dose and a multiplicative model. Risk Analysis, 19, 309–320.
   PubMedGoogle Scholar
• GROOPMAN, J. D. and KENSLER, T. W. 1999, The light at the end of the tunnel for chemical specific biomarkers: daylight or headlight? Carcinogenesis, 20, 1–11.
   PubMed Web of Science ®Google Scholar
• GROOPMAN, J. D. and SKIPPER, P. L. (editors), 1991, Molecular Dosimetry and Human Cancer: Analytical, Epidemiological and Social Considerations (Boca Raton: CRC Press).
   Google Scholar
• GUPTA, R. C. 1985, Enhanced sensitivity of 32P-postlabeling analysis of aromatic carcinogen:DNA adducts. Cancer Research, 45, 5656–5662.
   PubMed Web of Science ®Google Scholar
• HAGMAR, L., TORNQVIST, M., NORDLANDER, C., ROSEN, I., BRUZE, M., KAUTIAINEN, A., MAGNUSSON, A. L, MALMBERG, B., APREA, P., GRANATH, F. and AXMON, A. 2001, Health effects of occupational exposure to acrylamide using hemoglobin adducts as biomarkers of internal dose. Scandinavian Journal of Environmental Health, 27, 219–226.
   PubMed Web of Science ®Google Scholar
• HATJFROLD, V., JAKTJBOWSKI, M., JANASLK, B., LIGOCKA, D., BUCHET, J.-P., BERGAMASCH, I. E., MANINI, P., MUTTI, A., GHITTORI, S., ARAND, M., HANGEN, N., OESCH, F., HIRVONEN, A. and LISON, D. 2002, Interest of genotyping and phenotyping of drug metabolising enzymes for the interpretation of biological exposure to styrene. Pharmacogenetics, 12, 691–702.
   Google Scholar
• HEMMINKI, K, DICKEY, C., KARLSSON, S., BELL, D., Hsu, Y., TSAI, W Y., MOONEY, L A., SAVELA, K. and PERERA, F P. 1997, Aromatic DNA adducts in foundry workers in relation to exposure, lifestyle and CYP1A1 and glutathione M1 transferase genotype. Carcinogenesis, 18, 345–350.
   PubMed Web of Science ®Google Scholar
• HEMMINKI, K, GRZBOWSKA, E., CHORAZY, M., TWARDOWSKA-SAUCHA, K., SROCZYNSKI, J. W., PUTNAM, K L., RANDERATH, K., PHILLIPS, D. H., HEWER, A., SANTELLA, R M., YOUNG, T. L. and PERERA, F P. 1990, DNA adducts in humans environmentally exposed to aromatic compounds in an industrial area of Poland. Carcinogenesis, 11, 1229–1231.
   Google Scholar
• HEMMINKI, K, SODERLING, J., ERICSON, P., NORBECK, H. E. and SEGERBACK, D. 1994a, DNA adducts among personnel servicing and loading diesel vehicles. Carcinogenesis, 15, 767–769.
   PubMed Web of Science ®Google Scholar
• HEMMINKI, K., ZHANG, L F., KRUGER, J., AurRup, H., TORNQVIST, M. and NORBECK, H. E. 1994b, Exposure of bus and taxi drivers to urban pollutants as measured by polycyclic aromatic hydrocarbon DNA adducts. Toxicology Letters, 72, 171–174.
   PubMed Web of Science ®Google Scholar
• HENDERSON, R. F., BEcirrom, W. E., BOND, J. A. and SUN, J. D. 1989, The use of biological markers in toxicology. Critical Reviews in Toxicology, 20, 65–82.
   PubMed Web of Science ®Google Scholar
• HENRY, C. J., PHILLIPS, R, CARPANINI, F, CORTON, C. J., CRAIG, K, IGARASHI, K, LEBOETJF, R., MARCHANT, G., OSBORNE, K, PENNIE, W. D., SNum, L L, TETA, M. J. and Vu, V. 2002, Use of genomics in toxicology and epidemiology: findings and recommendations of a workshop. Environmental Health Perspectives, 110, 1047–1050.
   PubMed Web of Science ®Google Scholar
• HERBERT, R., MARCUS, M., WOLFF, M. S., PERERA, F. P., ANDREWS, L., GODBOLD, J. H., RIVERA, M., Lu, X. Q. and LANDRIGAN, P. L. 1990, Detection of adducts of deoxyribonucleic acid in white blood cells of roofers by postlabelling. Relationship of adduct levels to measures of exposures to polycyclic aromatic hydrocarbons. Scandinavian Journal of Work and Environmental Health, 16, 135–143.
   PubMed Web of Science ®Google Scholar
• IARC, 1999a, Re-evaluation of Some Organic Chemicals, Hydrazine and Hydrogen Peroxide, 71 Part 1. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans (Lyon: IARC), 1,3-Butadiene. pp. 109–225.
   Google Scholar
• IARC, 1999b, Metabolic Polymorphisms and Susceptibility to Cancer. Scientific Publ. No. 148, edited by P. Vineis, N. Malats, M. Lang, A. d'Errico, N. Caporaso, J. Cuzick and P. Boffetta (Lyon: IARC). IKEDA, M. 1999, Solvents in urine as exposure markers. Toxicology Letters, 108, 99–106.
   PubMedGoogle Scholar
• KENSLER, T., BUCKS-EY, T., BUCKPITT, A. R., LIBER, H. L., PETKAU, J., REED, D. J. and TANNENBATJM, S. 2003, Commentary, health review committee. In Biomarkers in Czech Workers Exposed to 1,3-Butadiene: A Transitional Epielemiologic Study. Report No. 116 (Cambridge, MA: Health Effects Institute), pp. 143–162.
   Google Scholar
• KOC, H. and SWENBERG, J. A. 2002, Applications of mass spectrometry for quantitation of DNA adducts. Journal of Chromatography B: Analytical, Technological and Biomedical Life Sciences, 778, 323–343.
   PubMed Web of Science ®Google Scholar
• LEE, B. M. and SANTELLA, R M. 1988, Quantitation of protein adducts as a marker of genotoxic exposure: immunologic detection of benzo[a]pyrene-globin adducts in mice. Carcinogenesis, 9, 1773–1777.
   PubMed Web of Science ®Google Scholar
• LEWTAS, J., WALSH, D., WILLIAMS, R. and DOBIAS, L 1997, Air pollution exposure-DNA adduct dosimetry in humans and rodents: evidence for non-linearity at high doses. Mutation Research, 378, 51–63.
   Google Scholar
• MANZO, L., ARTIGAS, F., MARTINEZ, E., MUTTI, A., BERGAMASCHI, E., NICOTERA, P., TONINI, M., CANDURA, S. M., RAY, D. E. and COSTA, L G. 1996, Biochemical markers of neurotoxicity. A review of mechanistic studies and applications. Human and Experimental Toxicology, 15 (Suppl. 1), S20–S35.
   Google Scholar
• MITELMAN, F. 1994, Catalog of Chromosome Aberrations in Cancer, 5th edn (New York: Wiley). MurroRAM, D. S., WEDZICHA, B. L and DODSON, A. T. 2002, Acrylamide is formed in the Maillard reaction. Nature, 419, 448.
   Google Scholar
• MUTTI, A. 1989, Detection of renal diseases in humans: developing markers and methods. Toxicology Letters, 46, 177–191.
   PubMed Web of Science ®Google Scholar
• MUTTI, A. 1995, Use of intermediate end-points to prevent long-term outcomes. Toxicology Letters, 77, 121–125.
   PubMedGoogle Scholar
• MUTTI, A. 1999, Biological monitoring in occupational and environmental toxicology. Toxicology Letters, 108, 77–89.
   PubMedGoogle Scholar
• MUTTI, A., BERGAMASCHI, E., Gurrrom, S., IMBRIANI, M. and FRANCHIN II. 1993, On the need of a sampling strategy in biological monitoring: the example of hexane exposure. Internal Archives on Occupational and Environmental Health, 65, S171–S175.
   Google Scholar
• NRC (NATIONAL RESEARCH CouNcil.), 1989, Biologic Markers in Reproductive Toxicology (Washington, DC: National Academy Press).
   Google Scholar
• ORPHANLDES, G. and KIMBER, I. 2003, Toxicogenetics: applications and opportunities. Toxicology Science, 75, 1–6.
   PubMedGoogle Scholar
• OVREBO, S., HAUGEN, A., PHILLIPS, D. H. and HEWER, A. 1992, Detection of polycyclic aromatic hydrocarbon-DNA adducts in white blood cells from coke-oven workers: correlation with job categories. Cancer Research, 52, 1510–1514.
   PubMed Web of Science ®Google Scholar
• PEARCE, N., DE SANJOSE, S., BOFFETTA, P., KOGEVINAS, M., SARACCI, R and SAVTTZ, D. 1995, Limitations of biomarkers of cancer exposure in cancer epidemiology. Epidemiology, 6, 190–194. PENNIE, W. D. 2002, Custom cDNA microarrays, technologies and applications. Toxicology, 181–182, 551–554.
   Google Scholar
• PENNIE, W. D., TUGWOOD, J. D., OLIVER, G. J. and KIMBER, I. 2000, The principles and practice of toxicogenomics: applications and opportunities. Toxicology Science, 54, 277–283.
   PubMed Web of Science ®Google Scholar
• PERERA, F P. 1995, Molecular epidemiology and prevention of cancer. Environmental Health Perspectives, 103 (Suppl. 8), 233–236.
   PubMedGoogle Scholar
• PERERA, F. P. 2000, Molecular epidemiology: on the path to prevention. Journal of the National Cancer Institute, 92, 602–612.
   PubMedGoogle Scholar
• PERERA, F. P. and WEINSTEIN, I. B. 2000, Molecular epidemiology: recent advances and future directions. Carcinogenesis, 21, 517–524.
   PubMed Web of Science ®Google Scholar
• PERERA, F P. and WilyAorr, R. M. 1994, Biomarkers and molecular epidemiology in mutation/cancer research. Mutation Research, 313, 117–129.
   Google Scholar
• PERERA, F. P., ILI-MAN, S. M., KINNEY, P. L, WHYATT, R M., KELVIN, E. A., SHEPARD, P., EVANS, D., FULILOVA, M., FoRD, J., MILLAR, R L, MEYER, I. H. and RAUH, V A. 2002, The challenge of preventing environmentally related disease in young children: community-based research in New York City. Environmental Health Perspectives, 112, 197–204.
   Google Scholar
• PERERA, F. P., MOONEY, L A., DICKEY, C. P., SANTELLA, R M., BELL, D., BLANER, W, TANG, D. and WHyxrr, R M. 1996, Molecular epidemiology in environmental carcinogenesis. Environmental Health Perspectives, 104 (Suppl. 3), 441–443.
   PubMedGoogle Scholar
• PHILLIPS, D. H. 1997, Detection of DNA modifications by the 32P-postlabelling assay. Mutation Research, 378, 1–12.
   PubMed Web of Science ®Google Scholar
• PHILLIPS, D. H. and CASTEGNARO, M. 1993, Results of an interlaboratory trial of 32P-postlabelling. In Postlabelling Methods for Detection of DNA Adducts. edited by D. H. Phillips, M. Castegnaro and H. Bartsch. Scientific Publ. No. 124 (Lyon: IARC), pp. 35–49.
   Google Scholar
• PHILLIPS, D. H. and CASTEGNARO, M. 1999, Standardization and validation of DNA adduct postlabelling methods: report of interlaboratory trials and production of recommended protocols. Mutagenesis, 14, 301–315.
   PubMed Web of Science ®Google Scholar
• PHILLIPS, D. H., HEMMINKI, K, ALHONEN, A., HEWER, A. and GROVER, P. 1988b, Monitoring occupational exposure to carcinogens: detection by 32P-postlabelling of aromatic DNA adducts in white blood cells from iron foundry workers. Mutation Research, 204, 531–541.
   PubMed Web of Science ®Google Scholar
• PHILLIPS, D. H., HEWER, A., MARTIN, C. N., GARNER, R C. and KING, M. M. 1988a, Correlation of DNA adduct levels in human lung with cigarette smoking. Nature, 336, 790–792.
   PubMed Web of Science ®Google Scholar
• POIRIER, M. C. 1997, DNA adducts as exposure biomarkers and indicators of cancer risk. Environmental Health Perspectives, 105 (Suppl. 4), 907–912.
   PubMedGoogle Scholar
• POTTER, D., BLAIR, D., DAVIES, R., WATSON, W. P. and WRIGHT, A. S. 1989, The relationship between alkylation of haemoglobin and DNA in Fischer 344 rats exposed to [14g-ethylene oxide. Archives in Toxicology. Suppl., 13, 254–257.
   Google Scholar
• QIAN, G. S., Ross, R K, Yu, M. C., YUAN, J. M., GAO, Y. T, HENDERSON, B. E., WOGAN, G. N. and GROOPMAN, J. D. 1994, A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiology and Biomarkers Prevention, 3, 3–10.
   PubMed Web of Science ®Google Scholar
• Qu, S.-X., LEIGH, J., KOELIVIEYER, H. and STACEY, N. H. 1997, DNA adducts in coal miners: association with exposures to diesel engine emissions. Biomarkers, 2, 95–102.
   Google Scholar
• RANDERATH, K, REDDY, M. V. and GurrA, R. C. 1981, 32P-labelling test for DNA damage. Proceedings of the National Academy of Sciences. USA, 78, 6126–6129.
   PubMed Web of Science ®Google Scholar
• RAPPAPORT, S. M. 1995, Biological monitoring and standard setting in the USA: a critical appraisal. Toxicology Letters, 77, 171–182.
   PubMedGoogle Scholar
• REDDY, M. V, HEMMINKI, K and RANDERATH, K 1991, Postlabelling analysis of polycyclic aromatic hydrocarbon—DNA adducts in white blood cells of foundry workers. Journal of Toxicology and Environmental Health, 34, 177–185.
   Google Scholar
• REDDY, M. V. and RANDERATH, K 1986, Nuclease P1-mediated enhancement of sensitivity of 32 P-postlabeling test for structurally diverse DNA adducts. Carcinogenesis, 7, 1543–1551. ROUTLEDGE, M. N., GARNER, R C., JENKINS, D. and Cuzicx, J. 1992, 32P-postlabelling analysis of
   Google Scholar
• DNA from human tissues. Mutation Research, 282, 139–145.
   Google Scholar
• SAVELA, K, HEM1VUNKI, K, HEWER, A., PHILLIPS, D. H., PUTMAN, K L and RANDERATH, K 1989, Interlaboratory comparison of the 32P-postlabelling assay for aromatic DNA adducts in white blood cells of iron foundry workers. Mutation Research, 224, 485–492.
   Google Scholar
• SCHOKET, B., POIRIER, M. C., MAYER, G., TOROK, G., KOLOZSI-RINGEL.HANN, A., BOGNAR, G., BIGBEE, W. L. and VINCZE, I. 1999, Biomonitoring of human genotoxicity induced by complex occupational exposures. Mutation Research, 445, 193–203.
   Google Scholar
• SHARP, R. R. and ZIGAS, P. H. 2002, Ethical and legal considerations in biological markers research. In Biomarkers of Environmentally Associated Disease, edited by S. H. Wilson and W. A. Suk (Boca Raton: CRC Press), pp. 17–25.
   Google Scholar
• SIMONS, A. M., PHILLIPS, D. H. and COLEMAN, D. V. 1993, Damage to DNA in cervical epithelium related to smoking tobacco. British Medical Journal, 306, 1444–1448.
   PubMedGoogle Scholar
• SMARGIASSI, A. and Mum, A. 1999, Peripheral biomarkers and exposure to manganese. Neurotox-icology, 20, 401–406.
   PubMed Web of Science ®Google Scholar
• SOLOMON, E., BORROW, J. and GODDARD, A. 1991, Chromosome aberrations and cancer. Science, 254, 1153–1160.
   PubMed Web of Science ®Google Scholar
• STADLER, R H., BLANK, I., VARGA, N., ROBERT, F., HAU, J., GUT, P. A., ROBERT, M.-C. and RIEDLKER, S. 2002, Acrylamide from Maillard reaction products. Nature, 419, 449.
   Google Scholar
• SWENBERG, J. A., CHRISTOVA-GEORGUIEVA, N. I., UPTON, P. B., RANASINGHE, A., SCHEELER, N., Wu, K.-Y., YEN, T.-Y. and HAYES, R. 2000, Part V, Hemoglobin adducts as biomarkers of butadiene exposure and metabolism. In 1,3-Butadiene: Cancer, Mutations, and Adducts. Research Report No. 92 (Cambridge, MA, Health Effects Institute).
   Google Scholar
• SWENBERG, J. A., Koc, H., UPTON, P. B., GEORGU1EVA, N., RANASINGHE, A., WALKER, V. E. and HENDERSON, R 2001, Using DNA and hemoglobin adducts to improve the risk assessment of butadiene. Chemico-Biological Interactions, 135–136, 387–403.
   Google Scholar
• TAREKE, E., RYDBERG, P., KARLSSON, P., ERIKSSON, S. and TORNQVIST, M. 2002, Analysis of acrylamide, a carcinogen formed in heated foodstuffs. Journal of Agriculture and Food Chemistry, 50, 4998–5006.
   PubMed Web of Science ®Google Scholar
• TIMBRELL, J. A. 1998, Biomarkers in toxicology. Toxicology, 129, 1–12.
   PubMed Web of Science ®Google Scholar
• TORNQVIST, M. and EHRENBERG, L. 1994, On cancer risk estimation of urban air pollution. Environmental Health Perspectives, 102 (Suppl. 4), 173–181.
   PubMedGoogle Scholar
• TORNQVIST, M. and HINDSO LANDIN, H. 1995, Hemoglobin adducts for in vivo dose monitoring and cancer risk estimation. Journal of Occupational and Environmental Medicine, 37, 1077–1085.
   PubMed Web of Science ®Google Scholar
• TORNQVIST, M., FRED, C., HAGLUND, J., HELI-EBERG, H., PAULSSON, B. and RYDBERG, P. 2002, Protein adducts: quantitative analysis and qualitative aspects of their formation, analysis and applications. Journal of Chromatography B, Analytical Technology Biomedical Life Sciences, 778, 279–308.
   PubMed Web of Science ®Google Scholar
• TORNQVIST, M., MAGNUSSON, A. L., FARMER, P. B., TANG, Y. S., JEFFREY, A. M., WAZNEH, L., BEULINK, G. D., VAN DER WAAL, H. and VAN SITTERT, N. J. 1992, Ring test for low levels of N-(2-hydroxyethyl)valine in human hemoglobin. Annals of Biochemistry, 203, 357–360.
   Google Scholar
• TORNQVIST, M., MOWRER, J., JENSEN, S. and EHRENBERG, L 1986, Monitoring of environmental cancer initiators through hemoglobin adducts by a modified Edman degradation method. Annals of Biochemistry, 154, 255–266.
   Google Scholar
• TOTSUKA, Y, FuvuTomE, K., TAKAHASHI, M., TAKAHASHI, S., TADA, A., SUGIMURA, T. and WAKABAYASHI, K 1996, Presence of N2-(deoxyguanosin-8-y1)-2-amino-3,8-dimethylimi- dazo [4,54] quinoxaline (dG-C8-MeIQx) in human tissues. Carcinogenesis, 17, 1029–1034.
   Google Scholar
• TRULL, A. K., DEMERS, L. M., HOLT, D. W., JOHNSTON, A., TREDGER, J. M. and PRICE, C. P. (editors) 2002, Biomarkers of Disease (Cambridge: Cambridge University Press).
   Google Scholar
• TUGWOOD, J. D. and BEcvErr, K. M. 2002, Genomics and biomarkers of disease. In Biomarkers of Disease, edited by A. K. Trull, L. M. Demers, D. W. Holt, A. Johnston, J. M. Tredger and C. P. Price (Cambridge: Cambridge University Press), pp. 291–298.
   Google Scholar
• UK HEALTH and SAFETY ExEcuTivE 1992, Biological Monitoring for Chemical Exposures in the Workplace. Guidance Note EH 56 (London: HMSO).
   Google Scholar
• VAINIO, H. 2001, Use of biomarkers in risk assessment. International Journal of Hygiene and Environmental Health, 204, 91–102.
   PubMed Web of Science ®Google Scholar
• VAN SCHOOTEN, F. J., GODSCHALK, R. W. L., BREEDIJK, A., Ms, L. M., KRIEK, E., Spiv...A, H., WIGEouT, G., Bs, P., VAN'T VEER, L and VAN ZANDWIJK, N. 1997, 32P-postlabelling of aromatic DNA adducts in white blood cells and alveolar macrophages of smokers: saturation at high exposures. Mutation Research, 378, 65–75.
   Google Scholar
• VAN SITTERT, N. J. 1984, Biomonitoring of chemicals and their metabolites. In Monitoring Human Exposure to Carcinogenic and Mutagenic Agents. Scientific Publ. No. 59, edited by A. Berlin, M. Draper, K. Hemminki and H. Vainio (Lyon: IARC), pp. 153–172.
   Google Scholar
• VAN SIII BRT, N. J., DE JONG, G., CI-ARE, M. G., DAVIES, R, DEAN, B. J., WREN, L J. and WRIGHT, A. S.1985, Cytogenetic, immunological, and haematological effects in workers in an ethylene oxide manufacturing plant. British Journal of Industrial Medicine, 42, 19–26.
   Google Scholar
• VAN SITTERT, N. J., MEGENS, H. J., WATSON, W. P. and BOOGAARD, P. J. 2000, Biomarkers of exposure to 1,3-butadiene as a basis for cancer risk assessment. Toxicological Sciences, 56, 189–202.
   PubMedGoogle Scholar
• VAN WELIE, R T. H., VAN DIJK, R G. J. M., VERMEULEN, N. P. E. and VAN SIILERT, N. J. 1992,Mercapturic acid, protein adducts, and DNA adducts as biomarkers of electrophilic chemicals. Critical Reviews in Toxicology, 22, 271–306.
   Google Scholar
• VINEIS, P. and MCMICHAEL, A. J. 1998, Bias and confounding in molecular epidemiology studies: special considerations. Carcinogenesis, 19, 2063–2067.
   PubMedGoogle Scholar
• WAKABAYASHI, K., TOTSUKA, Y, FuvuTomE, K, OGURI, A., USHIYAMA, H. and SUGIMURA, T. 1997, Human exposure to mutagenic/carcinogenic heterocyclic amines and comutagenic beta-carbo-lines. Mutation Research, 376, 253–259.
   PubMed Web of Science ®Google Scholar
• WALSH, J. E. 1962, Non-parametric confidence intervals and tolerance regions. In Contributions to Order Statistics, edited by A. Sarhan and B. Greenberg (New York: Wiley), pp. 136–143.
   Google Scholar
• WANG, J.-S., LINKS, J. M. and GROOPMAN, J. D. 2001, Molecular epidemiology and biomarkers. In Genetic Toxicology and Cancer Risk Assessment, edited by W. N. Choy (New York: Marcel Dekker), pp. 271–298.
   Google Scholar
• WATERFIELD, C. E. 1999, Biomarkers of effect and response. In General and Applied Toxicology, Vol. 3, 2nd edn, edited by B. Ballantyne, T. C. Marrs and T. Syversen (London: Macmillan), pp. 1855–1873.
   Google Scholar
• WATERFIELD, C. E. and TIMBRELL, J. A. 1999, Biomarkers - an overview. In General and Applied Toxicology, Vol. 3, 2nd edn, edited by B. Ballantyne, T. C. Marrs and T. Syversen (London, Macmillan), pp. 1841–1854.
   Google Scholar
• WATSON, W. P. 1987, Post-radiolabelling for detection of DNA damage. Mutagenesis, 5, 319–331. WATSON, W. P., BLEASDALE, C. and GOLDING, B. T. 1994, Chemicals and cancer: estimating the risk. Chemistry in Britain, 661–664.
   Google Scholar
• WATSON, W. P. and VAN SITIERT, N. J. 1996, Molecular approaches to assess cancer risks. Transactions of the Institution of Chemical Engineers, 73, Part B, S28—S31.
   Google Scholar
• WATSON, W. P. and WRIGHT, A. S. 1991, The direct determination of human carcinogens and assessment of low level risks. In Molecular Dosimetry and Human Cancer: Analytical, Epidemiological and Social Considerations, edited by J. D. Groopman and P. L. Skipper (Boca Raton: CRC Press), pp. 3–14.
   Google Scholar
• WHYATT, R. M. and PERERA, F. P. 1995, Application of biologic markers to studies of environmental risks in children and the developing fetus. Environmental Health Perspectives, 103 (Suppl. 6), 105–110.
   PubMedGoogle Scholar
• WILSON, S. H. and Sux, W. A. (editors) 2002, Biomarkers of Environmentally Associated Disease (Boca Raton: CRC Press).
   Google Scholar
• WRAITH, M. J., WATSON, W. P., EADSFORTH, C. V., VAN SITTERT, N. J., TORNQVIST, M. and WRIGHT, A. S. 1988, An immunoassay for monitoring human exposure to ethylene oxide. In Methods for Detecting DNA Damage in Humans: Applications in Cancer Epidemiology and Prevention. Scientific Publ. No. 89, edited by H. Bartsch, K. Hemminki and I. K. O'Neill (Lyon: IARC), pp. 271–274.
   Google Scholar
• WRIGHT, A. S., BRADSHAW, T. K. and WATSON, W. P. 1988, Prospective detection of genotoxic hazards. In Methods for Detecting DNA Damaging Agents in Humans: Applications in Cancer Epidemiology and Prevention. Scientific Publ. No. 89, edited by H. Bartsch, K. Hemminki and I. K. O'Neill (Lyon: IARC), pp. 237–248.
   Google Scholar
• YANG, K., AiRourn, L., PASTORELLI, R, RESTANO, J., GUANCI, M. and HEMMINKT, K 1996, Aromatic DNA adducts in lymphocytes of humans working at high and low traffic density areas. Chemico-Biological Interactions, 101, 127–136.
   Google Scholar
• YASUHARA, A., TANAKA, Y., HENGET-, M. and SHIBAMOTO, T. 2003, Gas chromatographic investigation of acrylamide formation in browning model systems. Journal of Agriculture and Food Chemistry, 51, 3999–4003.
   PubMed Web of Science ®Google Scholar
• YAYLAYAN, V. A., WNOROWSKI, A. and PEREZ LocAs, C. 2003, Why asparagine needs carbohydrates to generate acrylamide. Journal of Agriculture and Food Chemistry, 51, 1753–1757.
   PubMed Web of Science ®Google Scholar